PMID: 16649363May 3, 2006Paper

Selective disappearance of donor-specific antibodies and absence of acute rejection after liver transplantation in a patient with a strongly positive lymphocyte crossmatch

Archives of Iranian Medicine
Bahar Bastani

Abstract

We report on a young female, who received a cadaveric liver transplant from a donor who was a zero antigen match, and to whom she has had a strongly positive crossmatch. Immediately after transplantation, her panel reactive antibodies dropped from 55% to 0%, a value which remained for nearly 3 weeks. She subsequently, redeveloped her pretransplant anti-HLA antibodies, though at a lower level, with the exception of those specific to the donor HLA antigens. She also did not develop any acute rejection episodes during the 6 months of follow-up.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.